Compare IMCR & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMCR | HMN |
|---|---|---|
| Founded | 2008 | 1945 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2021 | 1991 |
| Metric | IMCR | HMN |
|---|---|---|
| Price | $35.54 | $46.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $67.00 | $46.75 |
| AVG Volume (30 Days) | ★ 259.5K | 249.6K |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | N/A | ★ 56.80 |
| EPS | N/A | ★ 3.95 |
| Revenue | $379,590,000.00 | ★ $1,675,600,000.00 |
| Revenue This Year | $32.28 | $7.70 |
| Revenue Next Year | $10.66 | $6.46 |
| P/E Ratio | ★ N/A | $11.77 |
| Revenue Growth | ★ 28.11 | 5.44 |
| 52 Week Low | $23.15 | $36.20 |
| 52 Week High | $40.72 | $48.33 |
| Indicator | IMCR | HMN |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 56.07 |
| Support Level | $35.41 | $45.43 |
| Resistance Level | $37.25 | $47.07 |
| Average True Range (ATR) | 1.58 | 0.77 |
| MACD | -0.21 | 0.09 |
| Stochastic Oscillator | 11.38 | 81.51 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.